These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 889815)

  • 21. Constitutive and induced hepatic microsomal cytochrome P-450 monooxygenase activities in male Fischer-344 and CD rats. A comparative study.
    Dent JG; Graichen ME; Schnell S; Lasker J
    Toxicol Appl Pharmacol; 1980 Jan; 52(1):45-53. PubMed ID: 6767296
    [No Abstract]   [Full Text] [Related]  

  • 22. The benzo(alpha)pyrene deoxyribonucleoside products isolated from DNA after metabolism of benzo(alpha)pyrene by rat liver microsomes in the presence of DNA.
    King HW; Thompson MH; Brookes P
    Cancer Res; 1975 May; 35(5):1263-9. PubMed ID: 1120312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The separation of the isomeric phenols of benzo(a)pyrene by high-performance liquid chromatography.
    Elnenaey EA; Schoor WP
    Anal Biochem; 1981 Mar; 111(2):393-400. PubMed ID: 7247033
    [No Abstract]   [Full Text] [Related]  

  • 24. Benzo(a)pyrene-4,5-oxide hydratase: assay, properties, and induction.
    Leutz JC; Gelboin HV
    Arch Biochem Biophys; 1975 Jun; 168(2):722-5. PubMed ID: 1137413
    [No Abstract]   [Full Text] [Related]  

  • 25. Microsomal metabolism on benzo(a)pyrene. Multiple effects of epoxide hydrase inhibitors.
    Fahl WE; Nesnow S; Jefcoate CR
    Arch Biochem Biophys; 1977 Jun; 181(2):649-64. PubMed ID: 900937
    [No Abstract]   [Full Text] [Related]  

  • 26. Assay and partial purification of epoxide hydrase from rat liver microsomes.
    Dansette PM; Yagi H; Jerina DM; Daly JW; Levin W; Lu AY; Kuntzman R; Conney AH
    Arch Biochem Biophys; 1974 Oct; 164(2):511-7. PubMed ID: 4460878
    [No Abstract]   [Full Text] [Related]  

  • 27. Regio- and stereoselectivity of various forms of purified cytochrome P-450 in the metabolism of benzo[a]pyrene and (-) trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene as shown by product formation and binding to DNA.
    Deutsch J; Leutz JC; Yang SK; Gelboin HV; Chiang YL; Vatsis KP; Coon MJ
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3123-7. PubMed ID: 277915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic microsomal epoxide hydrase: a sensitive radiometric assay for hydration of arene oxides of carcinogenic aromatic hydrocarbons.
    Jerina DM; Dansette PM
    Mol Pharmacol; 1977 Mar; 13(2):342-51. PubMed ID: 854025
    [No Abstract]   [Full Text] [Related]  

  • 29. Species differences in activating and inactivating enzymes related to the control of mutagenic metabolites.
    Oesch F; Raphael D; Schwind H; Glatt HR
    Arch Toxicol; 1977 Dec; 39(1-2):97-108. PubMed ID: 341853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of protein deficiency on the hepatic microsomal mixed function oxidase. III-Influence on aflatoxin B1 metabolism and epoxide hydrase activity.
    Adekunle AA; Hayes JR; Campbell TC
    Biochem Exp Biol; 1978; 14(1):45-53. PubMed ID: 105748
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolism of benzo[a]pyrene: conversion of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to highly mutagenic 7,8-diol-9,10-epoxides.
    Thakker DR; Yagi H; Lu AY; Levin W; Conney AH
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3381-5. PubMed ID: 1068451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chiral stationary phase high-performance liquid chromatographic resolution and absolute configuration of enantiomeric benzo[a]pyrene diol-epoxides and tetrols.
    Weems HB; Yang SK
    Chirality; 1989; 1(4):276-83. PubMed ID: 2642055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug detoxification: epoxide hydrolase.
    Oesch F
    Prog Clin Biol Res; 1983; 135():81-105. PubMed ID: 6320223
    [No Abstract]   [Full Text] [Related]  

  • 34. Enzymatic hydration of (18O)epoxides. Role of nucleophilic mechanisms.
    Hanzlik RP; Edelman M; Michaely WJ; Scott G
    J Am Chem Soc; 1976 Mar; 98(7):1952-5. PubMed ID: 1254854
    [No Abstract]   [Full Text] [Related]  

  • 35. Structural requirements for the metabolic activation of benzo[a]pyrene to mutagenic products: effects of modifications in the 4,5-, 7,8-, and 9,10-positions.
    Wood AW; Levin W; Lu AY; Ryan D; West SB; Yagi H; Mah HD; Jerina DM; Conney AH
    Mol Pharmacol; 1977 Nov; 13(6):1116-25. PubMed ID: 339055
    [No Abstract]   [Full Text] [Related]  

  • 36. Modification of benzo(a)pyrene metabolism with microsomes by addition of uridine 5'-diphosphoglucuronic acid.
    Nemoto N; Takayama S
    Cancer Res; 1977 Nov; 37(11):4125-9. PubMed ID: 908046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of the drug-metabolizing enzymes.
    Poland A
    IARC Sci Publ; 1982; (39):351-64. PubMed ID: 6818143
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of enzyme induction on the metabolism of benzo(a)pyrene and 3'-methyl-4-monomethylaminoazobenzene in the pregnant and fetal rat.
    Welch RM; Gommi B; Alvares AP; Conney AH
    Cancer Res; 1972 May; 32(5):973-8. PubMed ID: 5017744
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of smoking on benzo(a)pyrene metabolism by human placental microsomes.
    Vaught JB; Gurtoo HL; Parker NB; LeBoeuf R; Doctor G
    Cancer Res; 1979 Aug; 39(8):3177-83. PubMed ID: 36982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fetal and neonatal development of the microsomal monooxygenase system.
    Short CR
    Drug Metab Rev; 1976; 5(1):1-42. PubMed ID: 802085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.